| Stock | Company | % Portfolio | Shares Held | Market Value | Change in Shares | % Change | Quarter End Price | Source |
|---|---|---|---|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | -833,333 | Exited | 13F | ||||
| CNTA | Centessa Pharmaceuticals plc | -1,227,178 | Exited | 13F | ||||
| IPSC | Century Therapeutics, Inc. | -241,684 | Exited | 13F | ||||
| CMPX | Compass Therapeutics, Inc. | -547,498 | Exited | 13F | ||||
| DYN | Dyne Therapeutics, Inc. | -672,096 | Exited | 13F | ||||
| IGMS | IGM Biosciences, Inc. | -4,096,210 | Exited | 13D | ||||
| INSM | Insmed Incorporated (PRN) | -42,850,000 | Exited | 13F | ||||
| IONS | Ionis Pharmaceuticals, Inc. | -357,915 | Exited | 13F | ||||
| LPTX | Leap Therapeutics, Inc. | -404,744 | Exited | 13F | ||||
| PRME | Prime Medicine, Inc. | -1,028,466 | Exited | 13F | ||||
| RGLS | Regulus Therapeutics Inc. | -2,694,044 | Exited | 13F | ||||
| TSVT | 2seventy bio, Inc. | -2,497,526 | Exited | 13F | ||||
| CRSP | CRISPR Therapeutics AG | -654,099 | Exited | 13F |